The relationship between the prevalence or levels of anti-SARS-CoV-2 IgG or IgM in COVID-19 patients and their demographic characteristics, including sex, age, race, days after the onset of symptoms, or severity of symptoms was analyzed. This evidence concerns the gene CD40LG and COVID-19.